PPD

PPD Laboratories opens central lab in Shanghai

Tuesday, April 21, 2015 07:56 AM

Global CRO PPD has opened a central laboratory in Shanghai, China, to deliver global scientific and technical lab expertise to meet growing client demand for these services in China. The new facility, which has been established in association with Shanghai Clinical Research Center (SCRC), will provide high-quality data across a range of technologies and applications for all phases of pharmaceutical development.

More... »

Quest Diagnostics

PPD appoints Jon Denissen VP GMP laboratory services

Friday, April 3, 2015 10:18 AM

Pharmaceutical Product Development (PPD) has appointed Jon Denissen, Ph.D., as vice president of good manufacturing practices (GMP) laboratories. Denissen brings over 25 years of experience in the pharmaceutical and CRO industries. He is based in PPD’s GMP lab facility in Middleton, Wis.

More... »


Survey: PSI, INC Research, Chiltern rated top CROs by investigative sites

Wednesday, April 1, 2015 08:00 AM

More than 1,900 global investigative sites rate the best CROs for which to work in a new survey conducted by CenterWatch, a provider of global clinical trials information. The survey results were released in the April issue of The CenterWatch Monthly newsletter.

More... »

PPD first to migrate data to the Oracle Health Sciences Cloud

Thursday, March 26, 2015 02:58 PM

PPD is the first company to migrate trials from an on-site installation of Oracle Health Sciences’ Siebel Clinical Trial Management System to Siebel Clinical Trial Management System Cloud Service—creating a highly available, centralized trial database that lowers costs, simplifies management, improves the accuracy of multi-CRO clinical trial data and accelerates studies.

More... »

Society for Clinical Research Sites expands relationship with Acurian

Friday, March 13, 2015 12:30 PM

The Society for Clinical Research Sites (SCRS), a Ellicott City, Md.-based global trade organization representing clinical research sites, has announced an expanded relationship with Acurian, a full-service provider of global patient enrollment and retention solutions and a subsidiary of PPD.

More... »

Biosimilars Provide New Business Opportunities for Sites

Monday, March 9, 2015 08:00 AM

Significant factors involved in the growth and potential impact of biosimilars include budgetary pressures to reduce healthcare expenditures, patent expiries of blockbuster drugs, growing demand for low-cost alternatives, an increasingly aging population, government initiatives and rising incidences of various diseases.

More... »

PharmaTimes clinical research awards to be presented Feb. 26

Thursday, February 12, 2015 03:33 PM

The 2015’s PharmaTimes Clinical Researcher of the Year—The Americas awards will be presented Feb. 26 in North Carolina.

More... »

PPD expands GMP laboratory in Ireland

Wednesday, January 21, 2015 12:59 PM

Pharmaceutical Product Development (PPD), a global CRO based in Wilmington, N.C., has expanded its good manufacturing practices (GMP) operations in Athlone, Ireland, by adding a new, state-of-the-art laboratory for cell-based assays to its existing portfolio of services at the facility. The new lab provides GMP bioassay testing with dedicated areas to support cell culture activities with multiple assay endpoint expertise.

More... »

X-Chem collaborates with Janssen and Johnson & Johnson Innovation

Monday, January 12, 2015 02:40 PM

X-Chem, a privately held biotechnology company based in Waltham, Mass., applying its drug discovery platform to the generation of novel small molecule therapeutics, has announced a multi-target collaboration with Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.  The collaboration, which is being facilitated by Johnson & Johnson Innovation, Boston, focuses on the discovery and development of candidate molecules for the treatment of inflammatory diseases.

More... »

PPD, SNBL form Japanese clinical development joint venture

Monday, January 5, 2015 12:33 PM

Pharmaceutical Product Development (PPD), a global CRO based in Wilmington, N.C., and Japan-based Shin Nippon Biomedical Laboratories (SNBL) have formed a joint venture to provide a full range of clinical development services in Japan, including phase I-IV clinical trial monitoring, project management, site intelligence and activation, biostatistics, data management, medical writing, pharmacovigilance, regulatory and FSP services.

More... »


CWWeekly

April 20

Christie Clinic, PMG Research's 12th clinical research site, expands its geographic reach north to Illinois

Clinipace acquires Accovion to expand European presence, following an infusion of equity that could lead to more deals

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs